Oncology & Cancer

New genetic test can improve ovarian cancer treatment

A genetic test developed in a study at the University of Helsinki and Helsinki University Hospital identifies ovarian cancer patients who benefit from PARP inhibitors, a treatment option.

Medications

Study evaluates biomarker to help curb unnecessary antibiotic use

Testing for procalcitonin, a blood biomarker that is increased in people with a bacterial infection, could help physicians more quickly and effectively determine whether patients need antibiotics. Knowing that would ultimately ...

page 10 from 40